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Introduction: Crohn’s disease (CD) is a chronic illness with continuous and longstanding
treatment, which affects general state of health and life quality of patients.
Objectives: Evaluating the effects of Transpersonal Brief Psychotherapy (TBP) on general state
of  health and life quality of patients with CD.
Methods: Eleven people diagnosed with CD of both sexes and aged between 25 and 50 years
old  have been evaluated. The clinical method was used and the procedure consisted of treat-
ment  with TBP and data collection before and after psychotherapy. In data collection, the
following instruments were used: Sociodemographic Questionnaire (SDQ), Crohn’s Disease
Activity Index (CDAI), Inﬂammatory Bowel Disease Questionnaire (IBDQ) and General Health
Questionnaire (GHQ), with descriptive analysis of results and the statistical methodology
with Wilcoxon test.
Results: The procedure turned out to be effective to all instruments (p < 0.05) and the most
signiﬁcant result was in relation to general state of health (−40.4%) and life quality (35.3%).
The  disease activity has decreased by 38.1% on CDAI.
Conclusion: TBP has brought meaningful beneﬁts to patients with CD, inﬂuencing the clinical
picture, with reduction of the severity of the disease and, consequently, it has improved their
general state of health and life quality.© 2015 Sociedade Brasileira de Coloproctologia. Published by Elsevier Editora Ltda. All
rights reserved.∗ Corresponding author.
E-mail: arletesilvapsi@gmail.com (A.S. Acciari).
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Efeitos  da  Psicoterapia  Breve  Transpessoal  sobre  o  estado  de  saúde  geral
e  a  qualidade  de  vida  em  pacientes  com  doenc¸a de  Crohn
Palavras-chave:
Doenc¸as inﬂamatórias
intestinais
Qualidade de vida
Psicoterapia breve
Doenc¸a de Crohn
r  e  s  u  m  o
Introduc¸ão: A doenc¸a de Crohn (DC) é uma enfermidade crônica que exige tratamento con-
tínuo e prolongado, afetando a qualidade de vida e a saúde geral dos pacientes. Além do
tratamento clínico, recomenda-se o acompanhamento psicológico para o desenvolvimento
de  estratégias adaptativas.
Objetivo: Avaliar os efeitos da Psicoterapia Breve Transpessoal (PBT) sobre a qualidade de
vida  e estado geral de saúde de pacientes com DC, e possível correlac¸ão com a atividade da
doenc¸a.
Métodos: Foram avaliados 11 pacientes com diagnóstico de DC, de ambos os sexos, com
idade entre 25 anos e 55 anos. Utilizou-se o método clínico e o procedimento consistiu no
atendimento em PBT, com coleta de dados antes e depois da psicoterapia. Na coleta de
dados foi utilizado o Questionário Sociodemográﬁco (QSD), Índice de Atividade da Doenc¸a
de Crohn (IADC), Inﬂammatory Bowel Disease Questionnaire (IBDQ), Questionário de Saúde
Geral  de Goldberg (QSG), com análise descritiva para os resultados e estatística com o teste
de  Wilcoxon.
Resultados: A intervenc¸ão mostrou-se signiﬁcativamente eﬁcaz para todos os instrumentos
avaliados (p < 0,05), com melhor resultado para o estado de saúde geral (−40,4%) e qualidade
de  vida (35,3%). A atividade da doenc¸a apresentou uma reduc¸ão de 38,1% no IADC.
Conclusão: A PBT trouxe benefícios aos pacientes com DC, inﬂuenciando seu quadro clínico,
com reduc¸ão da severidade da doenc¸a, e consequentemente, melhorando o estado de saúde
geral e a qualidade de vida destes doentes.
©  2015 Sociedade Brasileira de Coloproctologia. Publicado por Elsevier Editora Ltda.
Todos os direitos reservados.
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Methodsntroduction
rohn’s disease (CD) is an Inﬂammatory Bowel Disease (IBD),
hich is a chronic illness that affects life quality and life
xpectation of patients. At the same time, the disease activity
s intimately related to impoverishment of life quality of these
atients.1–3
Norton et al.,4 assessing the impact of CD over patients life,
ave reported the following repercussions: (a) large physical
mpact due to abdominal and joint pain, diarrhea and ﬂatu-
ence; (b) impact on the diet due the removal of certain foods
r food groups; (c) psychological impact with embarrassing,
wkward and silent aspects of CD; (d) minusculo routine in the
ourse of the disease, with difﬁculty to share fears and inse-
urities; (e) great concern regarding the bathroom; (f) social
mpact and social avoidance and withdrawal; change in cir-
le of friends, traveling, leisure activities with children and
ports activities; (g) impact on professional life with reduction
f worked hours and career change; (h) impact on sexual life.
The psychosocial consequences and life quality of patients
ust be considered therapeutic.5 Besides medical accompa-
iment, there must be psychological, social and educational
upport.3,4,6–11 Psychotherapy is recommended even for
eriods of disease remission.12,13
Recently, the brief psychotherapies have presented great
xpansion as well as alternatives and techniques to attend
ifferent diseases, with themes regarding health and life qual-
ty. They allow good therapeutic results within few sessions;it focuses on symptoms, crisis, personality characteristics or
some kind of comprehension. It provides continence, compre-
hension of the sickening process and possible psychosomatic
interactions involved; this is accompanied by relief of anxiety
and symptomatic aspects.14–16
The therapist role is broader, free and responsible; it
requires experience as well as combination of procedures
to make the therapeutic sessions catalyzing agents that
accelerate and make possible the relations and healthier
experiences.15
The Transpersonal Integrative Approach (TIA), in its
structural and dynamical aspects, presents theoretical and
practical principles that are methodologically structured to
orient and sustain psychotherapeutic process in Transper-
sonal Brief Psychotherapy (TBP).16,17
The main objective of this study was to evaluate the effects
of TBP over the general state of health and life quality of CD
patients. The secondary objective was to observe possible cor-
relations between general state of health and life quality of
patients along with disease activity. In this study, there was
the participation of 11 patients with CD, who  were followed
in the process of TBP for 14 weeks, in individual sessions of
50 min.Eleven patients, of both sexes, diagnosed with CD and aged
between 25 and 55 years old, followed up at the Inﬂammatory
j). 2 0 1 5;3  5(3):162–167
Table 1 – Planning of the sessions with seven stages of
TIA.
Stage Instrument Technical
procedure
Recognition Exercise of
excellence
Symbolic
reorganization
Identiﬁcation Heuristics of
emotion and
graphics
Interactive
dynamics
Disidentiﬁcation Exercise of
source
Active
imagination
Transmutation Internal dialogs Symbolic
reorganization
Transformation The seven selves Interactive
dynamics
Elaboration The four doors Interactive
dynamics164  j coloproctol (rio 
Bowel Diseases Unit “Prof. Dr. Juvenal Ricardo Navarro Góes”,
at the University of Campinas (UNICAMP), were studied.
Patients bearing intestinal stomas, women who were pregnant
or lactating, patients with surgical treatment indication, previ-
ous or evident diagnosis of psychosis, those who were under
an individual or group psychotherapy process or alternative
treatments such as acupuncture and those who had lost the
segment were excluded. The project was approved by Research
Ethical Committee of the University of Campinas, under pro-
tocol number 953/2010, and with volunteer adhesion of the
participants. All of them were clariﬁed about the research pro-
cedures and its phases and they have signed the Informed
Consent.
The clinical method was used, with evaluation of the
results before and after psychotherapy. For evaluating, the fol-
lowing instruments were used:
(a) Sociodemographic Questionnaire (SDQ): elaborated in
order to get sociodemographic information from patients
regarding their identifying data, school level, professional
situation and clinical data.
(b) General Health Questionnaire (GHQ): questionnaire devel-
oped and validated by Goldberg in 1972; it is composed
of 60 items, distributed randomly, that measure the state
of general health (general factor) and ﬁve speciﬁc factors:
psychic stress, death wish, distrusting in own perfor-
mance, sleep disorders and psychosomatic disorders.18
(c) Inﬂammatory Bowel Disease Questionnaire (IBDQ): devel-
oped and validated in the United States in 1988, by Mitchell
e cols. from McMaster University; it has been translated
and adapted to Brazilian culture as a speciﬁc instrument
to evaluate life quality of Brazilian patients with IBD. It has
32 items that evaluate four dimensions: intestinal symp-
toms, systemic symptoms, social aspects and emotional
aspects. On the questionnaire these items are distributed
randomly in order to avoid bias in answers.19
(d) Crohn’s Disease Activity Index (CDAI): instrument devel-
oped and validated for characterizing the severity of CD,
allowing classifying patients according to intensity of the
inﬂammatory activity: disease in remission, with mild,
moderate, and severe fulminant disease.20
The TBP process took place for 14 weekly meetings, in indi-
vidual sessions of 50 min. The process included: (a) Sign of
Informed Consent; (b) screening interview along with ﬁlling
out of SDQ, exploration on the history of the disorder and
mean complaint; (c) initial evaluation, in which the patient
ﬁlled out the following questionnaires: GHQ and IBDQ; there-
fore, the patient was forwarded to see a doctor from the clinic
in order to ﬁll out the CDAI; (d) evolution of life history and self-
evaluation, contextualizing the present moment; (e) session
in TBP with weekly accompaniment; (f) ﬁnal evaluation, in
which the patient answered GHQ and IBDQ, once again, and
the CDAI was ﬁlled out by a doctor from the group; (g) feedback
interview.
The data were collected by the some investigator (A.S.A.)
and data registration was performed by the patient or the
researcher, which was a transcription of the spontaneous
speech of the patient. The study was done with previous plan-
ning and the established methodology to TBP was based onIntegration Exercise of loving
own body
Active
imagination
TIA principles.17 In order to articulate the interactive dynam-
ics with the seven steps of TIA in the TBP process, in planning,
an instrument to each step was elected (Table 1).
To ensure scientiﬁc character to therapeutic process, some
criteria have been established: (a) use of treatment protocol in
all interviews; (b) the duration of individual psychotherapeutic
process in 14 sessions of 50 min  once a week; (c) more  active
position by the therapist than in traditional psychotherapies,
sustaining the focus on current questions, stimulating active
position for patients in relation to their difﬁculties, conﬂicts
and needs, encouraging pro-activeness; (d) no interpreta-
tion and employ of interventions to promote consciousness,
comprehension, clariﬁcation and perception of unconscious
components by the patient himself; (e) use of patterned ver-
bal interventions, which intended to identify, qualify, quantify
and localize the purpose of situations; for what and to whom
it was addressed, with goal and objective to be achieved.
Statistical  analysis
Descriptive analysis with presentation of frequency tables for
categorical variables was applied and also measures of posi-
tion and dispersion for numeric variables. Wilcoxon test for
related samples was used for comparison of numeric meas-
ures that resulted in initial and ﬁnal evaluations. The level of
signiﬁcance is p < 0.05.
Results
The female gender (72.7%), married individuals (63.6%), with
children (72.7%) and those who completed High School (45.4%)
predominated among the patients. Majority (72.3%) had exer-
cised any of the activities, paid or unpaid.
Mean age was 40 (maximum of 50 and minimum of 29)
years old. The ﬁrst symptoms had appeared at the mean age
of 27 (maximum of 41 and minimum of 7) years old and the
average time for CD diagnosis was 9.7 (maximum of 20 and
minimum of 0.5) years.
The best results obtained were from GHQ, with improve-
ment of −40.4% in patients’ general state of health (Table 2).
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Table 2 – GHQ.
GHQ Average Standard deviation Minimum Median Maximum Variation % p-value
Psychosocial
disorders
Initial 2.9 0.7 1.5 3.1 3.7
Final 1.8 0.4 1.2 1.8 2.2
Difference −1.1 0.7 −2.1 −1.3 −0.2 −39.0 0.001a
Distrust of
own
performance
Initial 2.9 0.5 1.8 2.8 3.7
Final 1.7 0.4 1.1 1.8 2.2
Difference −1.2 0.6 −2.4 −1.1 −0.2 −40.1 0.001a
Sleep
disorders
Initial 3.2 0.6 1.7 3.2 3.8
Final 1.7 0.5 1.0 1.7 2.7
Difference −1.5 0.7 −2.5 −1.7 −0.3 −46.5 0.001a
Psychic
stress
Initial 3.2 0.6 1.9 3.4 3.9
Final 1.8 0.4 1.1 1.8 2.6
Difference −1.4 0.7 −2.3 −1.6 −0.1 −44.8 0.001a
Death wish Initial 2.0 0.7 1.0 2.0 2.9
Final 1.2 0.3 1.0 1.1 1.9
Difference −0.9 0.6 −1.6 −1.0 0.0 −42.9 0.004b
Total Initial 2.8 0.5 1.6 3.0 3.5
Final 1.7 0.3 1.2 1.6 2.2
Difference −1.2 0.6 −2.2 −1.1 −0.2 −40.4 0.001a
a Signiﬁcant at 0.1%.
b Signiﬁcant at 1% for Wilcoxon test.
Table 3 – IBDQ.
IBDQ Average Standard deviation Minimum Median Maximum Variation % p-value
Intestinal
aspects
Initial  44.5 7.1 32.0 45.0 53.0
Final 57.1 7.8 41.0 59.0 67.0
Difference 12.6 6.7 5.0 11.0 23.0 28.4 0.001a
Systemic
symptoms
Initial  17.0 4.7 10.0 16.0 27.0
Final 25.6 6.0 17.0 26.0 35
Difference 8.6 5.5 2.0 8.0 18.0 50.3 0.001a
Social
aspects
Initial  21.7 5.9 15.0 23.0 33.0
Final 29.1 5.5 19.0 32.0 35.0
Difference 7.4 4.6 2.0 6.0 18.0 33.9 0.001a
Emotional
aspects
Initial  11.7 3.8 5.0 13.0 16.0
Final 16.7 4.2 9.0 19.0 21.0
Difference 5.0 2.8 1.0 5.0 11.0 42.6 0.001a
Total Initial  94.9 17.8 71.0 94.0 129.0
Final 128.5 21.8 89.0 134.0 155.0
Difference 33.6 13.4 18.0 33.0 63.0 35.3 0.001a
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ca Signiﬁcant at 0.1% for Wilcoxon test.
he sleep disorder factor presented the most signiﬁcant
mprovement, with decrease of 46.5% in difﬁculties related
o sleep, followed by psychic stress (−44.8%), death wish
−42.9%), distrusting in own performance (−40.1%) and psy-
hosocial disorders (−39.0%).
The IBDQ presented an improvement of 35.3% in qual-
ty of life, whereas the systematic symptoms had the higher
mprovement (50.3%), followed by emotional aspects (42.6%),
ocial aspects (33.9%) and intestinal aspects (28.4%), as we can
bserve in Table 3.
The results of CDAI evidenciate a decrease of −38.1% in
isease activity (Table 4).
iscussionD represents a global public health matter at the present
oment3,11,21; it is a chronic inﬁrmity, with prolonged and
ontinuous treatment seeking adequate life quality.6–9,20–22It is possible that, due to multiplicity of clinical presen-
tations and similitude to other disorders, the diagnosis of
CD might be difﬁcult, making the adequate control of the
disease, especially at early stages, impossible, and imply-
ing in long periods of suffering, with physical and psychic
discomfort.7–9,22,23 Just as it has been demonstrated by sev-
eral epidemiological studies, the majority of patients in this
casuistry had the ﬁrst symptoms of the disease in their sec-
ond decade of life, and it took an average time of 10 years for
deﬁnitive diagnostic counting from the appearance of clinical
picture.6–9,20–22
Many studies have assessed the psychological issue and
recommend psychotherapy as part of the treatment for bet-
ter control of the disease and to improve patients’ life
10–13,24,25quality. However, few studies have been conducted
to evaluate the results of psychotherapy in these patients.25,26
In the present study, the patients went through TBP pro-
cess, under the referential from TIA. It has been considered
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Table 4 – CDAI.
CDAI Average Standard deviation Minimum Median Maximum Variation % p-value
Initial 187.4 92.9 84.0 161.0 356.0
Final 116.0 93.7 25.0 80.0 315.0
Difference −71.4 46.5 −181.0 −65.0 −20.0 −38.1 0.001a
a Signiﬁcant at 0.1% for Wilcoxon test.
r
1
1
1
1
1that the systemic and transdisciplinary approach, viewing
humans as bio-psycho-socio-spiritual beings, favors the com-
prehension of psychosomatic manifestations.16,17
Through the methodology used in this research, an
improvement of −40.4% in general state of heath of patients
and 35% in quality of life was observed, and a lower differ-
ence for intestinal aspects, with reduction of 28.4%. This factor
might be a reﬂection of the chronic aspects of CD, as described
by other authors.6–9,20–22
Deter et al.26 have also demonstrated that CD course is
inﬂuenced by psychotherapy; this study has observed a reduc-
tion of −38.1% in illness activity, what could be associated to
improvement in general state of health and quality of life of
the patients.
Although this paper may differ in means of meth-
ods, criteria of inclusion, and evaluation of results, its
ﬁndings are in consonance to other studies that eval-
uate the results of psychotherapy in patients with IBD,
among them CD, as well as other studies that have rec-
ognized the beneﬁts of psychotherapy, regardless of the
approach used.15,25,26 These results are also similar to other
studies that have evaluated IBD.5,10,12,13,24–30 However, it
is necessary to bring out the limitations of the study as
the casuistry is small and the subjectivity of evaluation,
once each individual interpret his own internal percep-
tions, makes an evaluation of themselves also and chooses
the alternatives that best ﬁt the state observed in self-
evaluation.
Conclusion
TBP has brought meaningful beneﬁts to patients with CD,
inﬂuencing the clinical picture with reduction of the sever-
ity of the disease, and, consequently, it has improved their
general state of health and life quality.
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